Wie hoch ist der Preis für IQ-AI Limited (IQAI)

Preis für IQ-AI Limited (IQAI) ist $0.01122579

Wie hoch ist die Marktkapitalisierung für IQ-AI Limited (IQAI)

Marktkapitalisierung für IQ-AI Limited (IQAI) ist $27.70K

IQ-AI Limited (IQAI) Aktiensplits

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.

Jahr	Aktien-Split	Multiplikator	Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.

Jahr

Aktien-Split

Multiplikator

Kumulierter Multiplikator

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Kumulierter Multiplikator	Land
GE HealthCare Technologies Inc. GEHC.US	-	US
Veeva Systems Inc. VEEV.US	-	US
Pro Medicus Limited PME.AX	-	AU
M3, Inc. MTHRY.US	-	JP
HealthEquity, Inc. HQY.US	-	US

Unternehmen

Anzahl der Aktiensplits

Kumulierter Multiplikator

Land